2019 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
2015 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
2012 | |
Criterium: | Position: |
Overall Score: | 900-1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | 70 |
Total Project Funding: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Networking Rank (Reputation): | > 1000 |
Partner Constancy: | 46 |
Project Leadership Index: | 75 |
Diversity Index: | 60 |
2011 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
Total Project Funding: | > 1000 |
Partner Constancy: | > 1000 |
Project Leadership Index: | > 1000 |
Diversity Index: | > 1000 |
2007 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Total number of projects: 7
As coordinator: 0
As participant: 7
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2019 | 0 | 9.168.652 | 11.000 | 1 | ||
2017 | 0 | 3.860.396 | 255.374 | 1 | ||
2016 | 0 | 7.850.000 | 0 | 1 | ||
2015 | 0 | 8.056.677 | 1.476.250 | 1 | ||
2012 | 0 | 3.816.703 | 211.851 | 1 | ||
2010 | 0 | 5.999.723 | 179.104 | 2 |
Total number of partners: 102
Partner loyalty:
Frequent Partner: (> 2 projects): 3
Rare Partner: 99
Frequent / Rare Partner Ratio: 0.03
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2019-10-01 | A safe DIVA vaccine for African Swine Fever control and eradication | VACDIVA | participant | 9.168.652 | 20 |
2017-04-01 | Host switching pathogens, infectious outbreaks and zoonosis; a Marie Sklodowska-Curie Training Network | HONOURs | participant | 3.860.396 | 13 |
2016-03-01 | Vaccine lot to Vaccine lot comparison by consistancy testing - Sofia ref.: 115924 | VAC2VAC | participant | 7.850.000 | 23 |
2015-04-01 | Engineering of Mycoplasma pneumoniae as a broad-spectrum animal vaccine | MycoSynVac | participant | 8.056.677 | 8 |
2012-06-01 | A systematic analysis of parasite metabolism - from metabolism to intervention | ParaMet | participant | 3.816.703 | 12 |
2010-04-01 | Improvement of current and development of new vaccines for theileriosis and babesios of small ruminants | PIROVAC | participant | 2.999.994 | 15 |
2010-02-01 | "Development of Vaccines for bTV, EHDV and AHSV" | ORBIVAC | participant | 2.999.729 | 18 |